
An outbreak of Ebola disease caused by the Bundibugyo virus remains in a period of intense transmission, in the Democratic Republic of the Congo. Since it's first detection in May, 6757 cases have been confirmed across...


science
Hosted by American Society for Microbiology · science · EN
Editors in Conversation is the official podcast of the American Society for Microbiology Journals. Editors in Conversation features discussions between ASM Journals Editors, researchers and clinicians working on the most cutting edge issues in the microbial sciences. Topics include laboratory diagnosis and clinical treatment of infectious diseases, antimicrobial resistance, epidemiology of infections, multidrug-resistant organisms, pharmacology of antimicrobial agents, susceptibility testing, and more.The podcast is directed to microbiologists, infectious diseases clinicians, pharmacists and basic, clinical and translational researchers interested in the microbial sciences. A particular emphasis is on basic, epidemiological and pharmacological aspects of infectious diseases, including antimicrobial resistance and therapeutics.
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
35%
Guest openness
Selective
Sign up to generate a grounded pitch for Editors in Conversation.
Signup to Generate a PitchEditors in Conversation is the official podcast of the American Society for Microbiology Journals. Editors in Conversation features discussions between ASM Journals Editors, researchers and clinicians working on the most cutting edge issues in the microbial sciences.
Recent episodes include "Ebola: Is Your Laboratory Prepared To Handle a Potential Case?" (2 October 2026, 48 minutes), "Group B Strep After Antibiotics: Survival, Persistence, and Evolution" (18 September 2026, 41 minutes), and "Diagnostic Access and Equity" (28 August 2026, 45 minutes).
Editors in Conversation publishes roughly every two weeks, with episodes averaging 42 minutes across 124 episodes.
Booking probability for Editors in Conversation is 35%, and the host is rated Selective on guests. Editors in Conversation requires a Pod Score of 80 or higher. Editors in Conversation's contact route on record: verified email.
The strongest fits for Editors in Conversation are Medical Labs & Imaging and Scientific Research & Development. Editors in Conversation has a science audience.
Editors in Conversation is a science podcast with 124 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

An outbreak of Ebola disease caused by the Bundibugyo virus remains in a period of intense transmission, in the Democratic Republic of the Congo. Since it's first detection in May, 6757 cases have been confirmed across...

In this episode of Editors in Conversation mBio edition , Marvin Whiteley speaks with Macy Pell and Shannon Manning about how group B Streptococcus (GBS) responds to antibiotics given during childbirth to prevent...

Episode #122
Equitable access to healthcare, and more specifically diagnostic testing, remains elusive globally, negatively impacting the health and wellbeing of all people. A not-so-distant illustration was access to testing during...

Multidrug-resistant Gram-negative infections remain one of the most urgent public health challenges worldwide, with some infections approaching the limits of available treatment options. In this special edition of...

Episode #119
It starts out with a couple of stomach twinges, maybe a little nausea, maybe some sharp pains, and then… before you know it, you are running to the closest toilet with which you become very, very familiar. Cyclospora...

Episode #118
So, you think you want a career in clinical microbiology? This field demands more than technical skill—it's driven by curiosity, growth, and the confidence to lead. From mastering diagnostics to pushing innovation and...

Episode #117
Artificial intelligence is revolutionizing the world in many ways. One of the most exciting applications of artificial intelligence is in the area of drug discovery. Particularly the discovery of antimicrobial molecules...

Episode #116
<p>Accurate AST results are the backbone of diagnostic stewardship, yet routine quality control (QC) might be missing subtle shifts that skew your hospital's annual antibiogram. By examining a real-world "silent...

Episode #115
<p>In this episode, a fascinating new bacteriophage, JS1. While most contractile phages (which inject DNA like a spring-loaded syringe) are rigid and straight, JS1 sports a curved, flexible tail that may help it...

Episode #114
<p>Is the future of cervical cancer screening non-invasive? Sharmila Manjeshwar, Ph.D. and Jeffrey Klausner M.D. MPH, discuss a breakthrough in HPV diagnostics: urine-based testing. While vaccination and clinical...

Episode #113
<p>Most microbiome research focuses on soil, oceans, or hosts. But the atmosphere itself harbors diverse communities of bacteria and fungi that move between ecosystems. This episode explores a recent mBio study...

Episode #112
<p>Matrix-assisted laser desorption ionization time of flight mass spectrometry (or MALDI) has revolutionized the clinical microbiology laboratory, enabling rapid, accurate and cheap identification of bacteria, yeast...

<p>In the inaugural episode of Editors in Conversation mBio edition, Marvin Whiteley speaks with Arturo Casadevall, infectious-disease physician-scientist, founding Editor in Chief of mBio, and a leading voice in fungal...

<p>The Interdisciplinary Meeting of Antimicrobial Resistance and Innovation has launched! The first version of IMARI brought together researchers, clinicians, industry leaders and policymakers to address one of the...

Episode #109
<p>Climate change is one of the most pressing issues facing humanity – and is not a future problem. Changes to the Earth's climate driven by emission of greenhouse gases have led to glaciers shrinking, plant and animal...

<p>This is a special live recording of Editors in Conversation at the 2025 ASM Global Research Symposium in Bengaluru, India. We explore the evolving landscape of drug-resistant pathogens—from the intracellular survival...

Episode #107
<p>I almost can't believe that we are wrapping up yet another year on the podcast this month, which has been going strong for 6 years now! And it has been another exciting year in the world of Clin Micro as well with...

Episode #106
<p>Prosthetic joint infections (PJI) remain among the most devastating complications in orthopedic surgery, with increasing incidence paralleling the growth in arthroplasty procedures worldwide. While treatment...

Episode #105
<p>It's that time of year, folks! No, not leaf-peeping season, or pumpkin spice season or even apple picking season – I'm talking respiratory virus season! The symphony of sniffles and coughs is just around the corner...

<p>Treponema pallidum, the causative agent of syphilis, has been around for what seems like forever, causing major outbreaks throughout the millennia and continuing to spread at high rates, globally, into today. When it...
Recent guests on Editors in Conversation. Study who booked and why before you pitch.
Senior Clinical Laboratory Advisor, Centers for Disease Control and Prevention
MT(ASCP)
Ph.D.
Michigan State University
PitchCentric classifies Editors in Conversation under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.

The ASHE Podcast

The AMR Studio

The Lancet Microbe in conversation with

Critical Conversations : Voices of AMR Experts

Listen to The Lancet Infectious Diseases

Emerging Infectious Diseases
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ